Cytosorbents (CTSO) Misses Q3 EPS by 15c

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.25), $0.15 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• Bankwell Financial Group, Inc. (BWFG) Tops Q2 EPS by 23c
• ACNB Corporation (ACNB) Tops Q2 EPS by 11c